Daiichi Sankyo Launches Anti-Clotting Drug In France, Italy
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo has launched its newly approved Effient (prasugrel) in France and Italy, expanding its reach to 22 nations to prevent blood clotting